Vicapsys Life Sciences, Inc.

VICP · OTC · SIC 2834: Pharmaceutical Preparations
41
SEC Filings
$1.46
Close 2026-03-30

Business Summary

Vicapsys Life Sciences, Inc. is a Florida-incorporated biopharmaceutical holding company developing encapsulated product candidates incorporating proprietary derivatives of the chemokine CXCL12 to create immunoprotection zones around cells, tissues, organs, and devices. Its lead product line VICAPSYN targets transplantation therapies including Type 1 Diabetes treatment via encapsulated human islet cell clusters. A second line, VYBRIN, addresses anti-fibrotic applications including post-surgical adhesion prevention, implantable device coating, and diabetic wound healing.

Latest Stock Quote

VICP 2026-03-30 $1.46 O:$1.46 H:$1.46 L:$1.46 Vol:0.0M VWAP:$1.46
origin leaf: fbfccc53ae3eea56097b9b4fb2860d1fdc87b3d3839db0d152343bc34c68c337

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2024-10-212023-12-310001493152-24-041809EDGAR45K words
2023-04-142022-12-310001493152-23-012267EDGAR—
2022-03-162021-12-310001493152-22-006994EDGAR—
2021-09-172020-12-310001493152-21-022984EDGAR—
2010-05-242009-12-310001144204-10-029858EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-01-102024-09-300001493152-25-001779EDGAR16K words
2025-01-102024-06-300001493152-25-001776EDGAR—
2025-01-102024-03-310001493152-25-001743EDGAR—
2023-11-142023-09-300001493152-23-040951EDGAR—
2023-08-142023-06-300001493152-23-028151EDGAR—
2023-05-152023-03-310001493152-23-017138EDGAR—
2022-11-212022-09-300001493152-22-033024EDGAR—
2022-08-162022-06-300001493152-22-023207EDGAR—
2022-05-132022-03-310001493152-22-013375EDGAR—
2021-11-122021-09-300001493152-21-027976EDGAR—
2021-09-202021-06-300001493152-21-023189EDGAR—
2021-09-202021-03-310001493152-21-023170EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2023-12-270001493152-23-046217EDGAR1K words
2023-06-300001493152-23-023183EDGAR—
2023-06-020001493152-23-019905EDGAR—
2023-05-170001493152-23-017970EDGAR—
2023-01-120001493152-23-001296EDGAR—
2022-09-280001493152-22-027017EDGAR—
2022-04-120001493152-22-009690EDGAR—
2010-07-010001144204-10-036040EDGAR—
2010-05-180001144204-10-028744EDGAR—
2010-04-260001144204-10-022071EDGAR—

41 total filings indexed. 14 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

type-1-diabetes-treatment transplantation-therapy post-surgical-adhesion-prevention implantable-medical-devices wound-healing-/-diabetic-ulcers fda-quality-system-regulations iso-13485

Company Identity

CIK0001468639
TickerVICP
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedFL

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fbcede84727a7c5878db3e5c35f274aa2519acca4363733495553664646b8dd0
parent: cd4f28e252f915121f4274d0258b7ee7045d5fefcd42098fe0f56031a65d9c5d
content hash: 17db7525ae0a399fae08a0b36054002fa2ccfde1eb4193b79ec737e6f457e2ab
signed: 2026-06-03T12:02:58.332Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf